Transient neonatal diabetes mellitus caused by a de novo ABCC8 gene mutation

Korean Journal of Pediatrics

Volumn 54, Issue 4, 2011, Pages 179-182

  Kong, Jung Hyun ^a   Kim, June Bum ^a  

^a Konyang University College of Medicine   (South Korea)

Author keywords

Diabetes mellitus; Infant; Mutation; Sulfonylurea receptor

Indexed keywords

EID: 79959836998     PISSN: 17381061     EISSN: 20927258     Source Type: Journal    
DOI: 10.3345/kjp.2011.54.4.179     Document Type: Article

References (13)

1. Flanagan SE, Patch AM, Mackay DJ, Edghill EL, Gloyn AL, Robinson D, et al. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes 2007;56:1930-1937.
2. Suzuki S, Makita Y, Mukai T, Matsuo K, Ueda O, Fujieda K. Molecular basis of neonatal diabetes in Japanese patients. J Clin Endocrinol Metab 2007;92:3979-3985.
3. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004;350:1838-1849.
4. Özlü F, Týker F, Yüksel B. Neonatal diabetes mellitus. Indian Pediatr 2006;43:642-645.
5. Kim MS, Kim SY, Kim GH, Yoo HW, Lee DW, Lee DY. Sulfonylurea therapy in two Korean patients with insulin-treated neonatal diabetes due to heterozygous mutations of the KCNJ11 gene encoding Kir6.2. J Korean Med Sci 2007;22:616-620.
6. Rafiq M, Flanagan SE, Patch AM, Shields BM, Ellard S, Hattersley AT. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 2008;31:204-209.
7. Batra CM, Gupta N, Atwal G, Gupta V. Transient neonatal diabetes due to activating mutation in the ABCC8 gene encoding SUR1. Indian J Pediatr 2009;76:1169-1172.
8. McGowan JE. Hypo- and hyperglycemia and other carbohydrate metabolism disorders. In: Thureen PJ, Hay WWJ, editors. Neonatal nutrition and metabolism. 2nd ed. Cambridge: Cambridge University Press, 2006;454-465.
9. Polak M, Cave H. Neonatal diabetes mellitus: a disease linked to multiple mechanisms. In: Chiarelli F, Dahl-Jørgensen K, Kiess W, editors. Diabetes in childhood and adolescence. Basel: Karger, 2005;10:72-83.
10. Babenko AP, Polak M, Cave H, Busiah K, Czernichow P. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 2006;355:456-466.
11. Zung A, Glaser B, Nimri R, Zadik Z. Glyburide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. J Clin Endocrinol Metab 2004;89:5504-5507.
12. Tonini G, Bizzarri C, Bonfanti R, Vanelli M, Cerutti F, Faleschini E, et al. Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene. Diabetologia 2006;49:2210-2213.
13. Mohamadi A, Clark LM, Lipkin PH, Mahone EM, Wodka EL, Plotnick LP. Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM. Pediatr Diabetes 2010;11:203-207.